Am. Low et al., Insights into the unusual alpha adrenoceptor subtype in dog saphenous veinusing phenoxybenzamine, J PHARM EXP, 288(1), 1999, pp. 148-156
Citations number
19
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
In the dog saphenous vein (DSV), phenylephrine (PE) responses through alpha
-1 adrenoceptors receptors are antagonized by both alpha-1 and alpha-2 rece
ptor antagonists. Furthermore, pretreatment with chloroethylclonidine (CEC)
eliminates prazosin binding but reduces rauwolscine binding by half (Danie
l et al., 1996). in new functional experiments, the effects of preincubatio
n with phenoxybenzamine (PBZ), an irreversible alpha adrenoceptor antagonis
t, on responses to PE and two selective alpha-2 adrenoceptor agonists were
evaluated. Also, the ability of prazosin or rauwolscine to prevent irrevers
ible losses of responses to these agonists when coincubated with PBZ was de
termined. Preincubation in PBZ (10-300 nM) concentration dependently reduce
d PE E-max and the calculated fraction of residual receptors (q). Preincuba
tion in PBZ (10-300 nM) increased K-B values for prazosin (30 and 100 nM) b
ut did not alter the K-B value for rauwolscine (50 nM) acting at the residu
al receptors from control values. Coincubation of PBZ with prazosin partial
ly prevented these PBZ actions (E-max partly restored) on responses to PE,
but coincubation of rauwolscine (less than or equal to 1 mu M) With PBZ, di
d not. Rauwolscine competitively inhibited responses to two alpha-2 adrenoc
eptor agonists (Schild plot pA(2) values near 9). Preincubation with PBZ co
ncentrations of greater than or equal to 300 nM caused >50% reduction in E-
max values of responses but did not alter the EC50 values for either agonis
t. Coincubation of rauwolscine with PBZ protected responses to alpha-2 agon
ists against PBZ(1 mu M) effects. This study shows that PE initiates contra
ctions at atypical alpha-1 adrenoceptors represented by all sites of PE act
ion. Rauwolscine antagonizes PE actions but does not protect against PBZ in
activation. Typical alpha-2 adrenoceptors are distinguished from the unusua
l alpha-1 adrenoceptors by their lesser sensitivity to PBZ and their protec
tion by rauwolscine from PBZ.